Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — August 16

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — August 16

Breakout stocks to buy or sell: Despite strong global market sentiments on the US Fed rate cut buzz, the Indian stock market remained flat on Wednesday. The Nifty 50 index finished marginally higher at 24,143, the BSE Sensex went up 149 points and closed at 79,105, whereas the Bank Nifty index went off 104 points … Read more

Breakout stocks to buy today: Trent to Orchid Pharma — Sumeet Bagadia recommends five shares to buy today

Breakout stocks to buy today: Trent to Orchid Pharma — Sumeet Bagadia recommends five shares to buy today

Breakout stocks to buy today: Following positive global market sentiments on cooling US recession fears, the Indian stock market finished higher on Friday. The Nifty 50 index surged 247 points to 24,364, the BSE Sensex shot up 819 points to 79,705, and the Bank Nifty index finished 325 points higher at 50,482.  However, due to … Read more

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today

Breakout stocks to buy or sell: Following a sell-off in the global markets on renewed US recession fear, the Indian stock market snapped its five-day winning steak on Friday. The Nifty 50 index crashed 311 points and closed at 24,699. The BSE Sensex tanked 885 points and ended at 80,981, whereas the Bank Nifty index … Read more

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — August 5

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — August 5

Buy or sell stocks: Following weak global market sentiments, the Indian stock market snapped its five-day winning steak on Friday. The Nifty 50 index crashed 311 points and closed at 24,699. The BSE Sensex tanked 885 points and ended at 80,981, whereas the Bank Nifty index corrected 226 points and finished at 51,337. The global … Read more

Stock market today: Trade setup for Nifty 50 to Q1 results 2024, five stocks to buy or sell on Monday — July 15

Stock market today: Trade setup for Nifty 50 to Q1 results 2024, five stocks to buy or sell on Monday — July 15

Stock market today: Despite mixed trends in the global markets, the Indian stock market ended higher on Friday. The Nifty 50 index finished 186 points higher at 24,502. The BSE Sensex shot up 622 points and closed at 80,519, whereas the Bank Nifty index ended marginally higher at 52,278. The rally in the Indian stock … Read more

Stock market today: Trade setup for Nifty 50 to Q1 results 2024, five stocks to buy or sell on Thursday — July 11

Stock market today: Trade setup for Nifty 50 to Q1 results 2024, five stocks to buy or sell on Thursday — July 11

Stock market today: Following weakness in the global markets, after the US Fed Jerome Powell did not offer any timeframe for the US Fed rate cut in 2024, the Indian stock market witnessed its worst session since 4th June 2024. The Nifty 50 index lost 108 points and closed at the 24,324 mark; the BSE … Read more

Stock to buy or sell: Yes Bank share price jumps 11% on strong Q1 results 2024 buzz. More steam left?

Stock to buy or sell: Yes Bank share price jumps 11% on strong Q1 results 2024 buzz. More steam left?

Stock to buy or sell: Yes Bank shares witnessed strong upside during Friday deals last week. Yes, Bank share price opened flat on Friday and remained sideways till 12:15 PM. The stock started gaining momentum at noon and touched an intraday high of ₹27.04 apiece on the NSE ahead of the closing bell. According to … Read more

Stock to buy: Anand Rathi assigns ‘Buy’ rating on Rossari Biotech shares, sees 26% upside

Stock to buy: Anand Rathi assigns ‘Buy’ rating on Rossari Biotech shares, sees 26% upside

Anand Rathi has assigned a ‘Buy’ rating on Rossari Biotech shares with a target price of ₹950 apiece, implying an upside potential of nearly 26% from its Thursday’s closing price. The specialty chemicals manufacturer Rossari Biotech is embarking on substantial ₹180 crore capex to yield an asset turnover of 4-5x on optimal utilisation. Anand Rathi … Read more